Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: A multi-institutional audit

Annals of Surgical Oncology

Volumn 14, Issue 10, 2007, Pages 2911-2917

  Moore, Katrina H ^a   Sweeney, Karl J ^a   Wilson, Meaghan E ^a   Goldberg, Jessica I ^a   Buchanan, Claire L ^b   Tan, Lee K ^a   Liberman, Laura ^a   Turner, Roderick R ^c   Lagios, Michael D ^d   Cody III, Hiram S ^a   Giuliano, Armando E ^c   Silverstein, Melvin J ^b   Van Zee, Kimberly J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c JOHN WAYNE CANCER INSTITUTE   (United States)

^d Breast Cancer Consultation Service   (United States)

Author keywords

Axillary lymph nodes; Breast carcinoma; Ductal carcinoma in situ; Lymph node metastases; Micrometastases; Prognosis; Sentinel lymph node biopsy; Survival

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST DUCT; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CARCINOMA IN SITU; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; SENTINEL LYMPH NODE; TREATMENT OUTCOME; TUMOR CELL; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NECROSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 34648829053     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9414-8     Document Type: Article

References (26)

1. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-52
2. Silverstein MJ, Gierson ED, Colburn WJ, et al. Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg Gynecol Obstet 1991;172:211-4
3. Pendas S, Dauway E, Giuliano AE, et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15-20
4. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000;7:636-42
5. Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001;67:513-9
6. Leidenius M, Salmenkivi K, von Smitten K, Heikkila P. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ. J Surg Oncol 2006;94:380-4
7. Tan JC, McCready DR, Easson AM, Leong WL. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy. Ann Surg Oncol 2007;14:638-45
8. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5
9. Rosen PP, Groshen S, Saigo PE, et al. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 1989;7:1239-51
10. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188-97
11. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer: International Breast Cancer Study Group. Lancet 1999;354:896-900
12. Tan LK, Giri D, Panageas K, et al. Occult/micrometastases in axillary lymph nodes of breast cancer patients are significant: a retrospective study with long-term follow-up. Proc Am Soc Clin Oncol 2002;21:37a
13. Kattan MW, Giri D, Panageas KS, et al. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy. Cancer 2004;101:2509-15
14. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995;345:1154-7
15. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401
16. American Joint Committee on Cancer. Breast. In: AJCC Cancer Staging Manual. New York: Springer, 2002:221-40
17. Kinne D, Petrek J, Osborne M, et al. Breast carcinoma in situ. Arch Surg 1989;124:33-6
18. Ward BA, McKhann CF, Ravikumar TS. Ten-year follow-up of breast carcinoma in situ in Connecticut. Arch Surg 1992;127:1392-5
19. Julien J-P, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet 2000;355:528-33
20. Temple LK, Baron R, Cody HS III, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 2002;9:654-62
21. Broekhuizen LN, Wijsman JH, Peterse JL, Rutgers EJ. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Eur J Surg Oncol 2006;32:502-6
22. Tamhane R, Dahlstrom JE, McCallum DD, Buckingham JM. The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ. Ann Surg Oncol 2002;9:999-1003
23. Lara JF, Young SM, Velilla RE, et al. The relevance of occult axillary micrometastasis in ductal carcinoma in situ-a clinicopathologic study with long-term follow-up. Cancer 2003;98:2105-13
24. El-Tamer M, Chun J, Gill M, et al. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ. Ann Surg Oncol 2005;12:254-9
25. Huo L, Sneige N, Hunt KK, et al. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 2006;107:1760-8
26. Lagios MD, Margolin FR, Westdahl P, Rose MR. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-24